Twenty-three of them revealed promising bioactivity on metabolic disorders, especially on lipid reduction on zebrafish embryos, a reduction of steatosis on a cell model, and an increase of ucp1 mRNA expression. This evidence concerns the gene UCP1 and steatosis.